- Trials with a EudraCT protocol (21)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
21 result(s) found for: Curettage.
Displaying page 1 of 2.
EudraCT Number: 2017-001701-33 | Sponsor Protocol Number: 58161 | Start Date*: 2017-05-19 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: Photodynamic therapy without curettage | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-001593-26 | Sponsor Protocol Number: H 1005 6002 - 05/07 | Start Date*: 2005-07-27 |
Sponsor Name:HERMAL Kurt Herrmann GmbH & Co OHG | ||
Full Title: Topical treatment of verrucae vulgares with Verrumal® in organtransplant recipients (OTR) – prospective, double-blind, placebo-controlled randomised trial | ||
Medical condition: Verrucae vulgares or common warts are benign epithelial tumors of the skin caused by infection with human papilloma viruses (HPV). Due to immunosuppression organ transplant recipients are at high r... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2007-001961-14 | Sponsor Protocol Number: WN07DE002 | Start Date*: 2007-06-28 | |||||||||||
Sponsor Name:Greater Glasgow and Clyde [...] | |||||||||||||
Full Title: A pilot study of the treatment of facial nodular and nodulocystic basal cell carcinoma with double curettage and cautery followed by application of imiquimod to the base. | |||||||||||||
Medical condition: Basal Cell Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-003479-52 | Sponsor Protocol Number: NL50433.068.14 | Start Date*: 2014-11-10 | |||||||||||
Sponsor Name:Maastricht University Medical Centre | |||||||||||||
Full Title: Surgical excision versus combined therapy with Curettage and Imiquimod for the treatment of Nodular Basal Cell Carcinoma: an open, non-inferiority, randomized controlled trial | |||||||||||||
Medical condition: Histologically proven primary nodular basal cell carcinoma ≥ 4mm and ≤ 20mm in diameter outside the face and hairy scalp. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001440-38 | Sponsor Protocol Number: 42647 | Start Date*: 2014-05-22 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: Methods to increase PpIX formation in the skin of healthy volunteers | |||||||||||||
Medical condition: Healthy volunteers - no medical condition is investigated but pharmaco kinetics | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-003358-15 | Sponsor Protocol Number: 2014-003358-15 | Start Date*: 2015-05-29 |
Sponsor Name:James Martin Shannon, MB Bch NUI | ||
Full Title: Intraoperative use of dexamethasone in day-case gynaecological surgery and its impact on sleep quality in the postoperative period. | ||
Medical condition: Postoperative sleep quality | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-002694-19 | Sponsor Protocol Number: 62449 | Start Date*: 2018-02-22 |
Sponsor Name:Radboud University Medical Centre | ||
Full Title: Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: a randomized double blind placebo-controlled comparison (M&M trial). | ||
Medical condition: Early pregnancy failure | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2016-003143-11 | Sponsor Protocol Number: CHUBX201620 | Start Date*: 2016-10-27 | |||||||||||
Sponsor Name:CHU de Bordeaux | |||||||||||||
Full Title: Effect of intra-venous ocytocine injection after fetal expulsion in management of third-stage of labor after second trimester medical pregnancy termination | |||||||||||||
Medical condition: second trimester medical pregnancy termination | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001209-34 | Sponsor Protocol Number: PRGFFC17 | Start Date*: 2018-05-28 |
Sponsor Name:FISEVI | ||
Full Title: Phase III CLINICAL TRIAL, MULCHNTRIC, RANDOMIZED, BLIND DOUBLE IN TWO PARALLEL GROUPS TO COMPARE THE EFFECTIVENESS AND SAFETY OF THE SIMPLE CLOSURE OF THE CRYPTTOGLANDULAR ANAL FISTULA WITH OR WITH... | ||
Medical condition: Patients with anal fistula | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001606-16 | Sponsor Protocol Number: 20062004 | Start Date*: 2009-01-16 | |||||||||||
Sponsor Name:Amgen Inc | |||||||||||||
Full Title: An Open-label, Multi-center, Phase 2 Study of Denosumab in Subjects with Giant Cell Tumor of Bone | |||||||||||||
Medical condition: Giant cell tumor of bone (GCTB) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) AT (Completed) FR (Completed) ES (Completed) GB (Completed) PL (Completed) IT (Completed) SE (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-002239-29 | Sponsor Protocol Number: WI18274 | Start Date*: 2006-03-06 |
Sponsor Name:F. Hoffmann - La Roche AG | ||
Full Title: A phase II prospective, open label, randomized, active-controlled, parallel group, multi-center ‘proof of concept’ trial in adult patients with complicated skin and skin structure infections requir... | ||
Medical condition: Treatment of adult patients with complicated skin and skin structure infections requiring hospitalization. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Completed) EE (Completed) DE (Completed) LV (Completed) HU (Completed) GR (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-001599-18 | Sponsor Protocol Number: BAY 12-8039/11974 | Start Date*: 2006-11-03 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A prospective, randomized, double dummy, double blind, multinational, multicenter trial comparing the safety and efficacy of sequential (intravenous/oral) moxifloxacin 400 mg once daily to intraven... | |||||||||||||
Medical condition: complicated skin and skin structure Infections | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) LT (Completed) BE (Completed) LV (Completed) FR (Completed) GR (Completed) IE (Completed) HU (Completed) ES (Completed) NL (Prematurely Ended) AT (Completed) IT (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000725-12 | Sponsor Protocol Number: Cx601-0303 | Start Date*: 2017-08-08 | |||||||||||
Sponsor Name:TiGenix, S.A.U. | |||||||||||||
Full Title: A phase III, randomized, double blind, parallel group, placebo controlled, international, multicentre study to assess efficacy and safety of Cx601, adult allogeneic expanded adipose-derived stem ce... | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) ES (Completed) HU (Completed) PL (Completed) GB (GB - no longer in EU/EEA) DE (Completed) FR (Completed) SE (Completed) DK (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000091-40 | Sponsor Protocol Number: RS03-2004 | Start Date*: 2005-11-08 | |||||||||||
Sponsor Name:ApoPharma Inc. | |||||||||||||
Full Title: Pivotal Study to Evaluate the Efficacy and Safety of Dermal - Living Skin Replacement (Dermal – LSR) in the Treatment of Chronic Diabetic Foot Ulcers | |||||||||||||
Medical condition: Chronic Diabetic Foot Ulcers | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-001182-21 | Sponsor Protocol Number: APC-01-2021 | Start Date*: 2021-06-21 | |||||||||||
Sponsor Name:University Hospital Puerta de Hierro Majadahonda, Madrid, Spain | |||||||||||||
Full Title: RANDOMIZED, UNICENTRIC, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL TO ASSESS THE EFFICACY OF PARACERVICAL ANESTHESIA FOR PAIN CONTROL DURING AN OFFICE HYSTEROSCOPY | |||||||||||||
Medical condition: Need to do an office Hysteroscopy for any reason | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-003895-15 | Sponsor Protocol Number: 82720 | Start Date*: 2022-02-23 | ||||||||||||||||
Sponsor Name:Bispebjerg Hospital, Department of Dermatology and Venereology | ||||||||||||||||||
Full Title: Impact of human papillomavirus (HPV) vaccination on burden of disease in patients with actinic keratosis ― a double-blind randomized controlled trial | ||||||||||||||||||
Medical condition: Actinic Keratosis (AK) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004007-13 | Sponsor Protocol Number: NCT-2010-1090 | Start Date*: 2013-09-06 | |||||||||||
Sponsor Name:Deutsches Krebsforschungszentrum (DKFZ | |||||||||||||
Full Title: A randomized, placebo-controlled, phase IIIb HPV vaccination trial with Gardasil® in patients with recurrent condylomata acuminata | |||||||||||||
Medical condition: Patients with recurrrent external condylomata acuminata located at the following genital regions: labia minora and majora, introitus vaginae, clitoris, prepuce, glans penis, coronal sulcus and fren... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002545-38 | Sponsor Protocol Number: 68943 | Start Date*: 2019-09-13 | |||||||||||||||||||||
Sponsor Name:Bispebjerg Hospital, Department of Dermatology | |||||||||||||||||||||||
Full Title: Biodistribution of ablative fractional laser-assisted topical delivery of Vismodegib in basal cell carcinomas. | |||||||||||||||||||||||
Medical condition: Basal cell carcinoma Simple nodular basal cell carcinoma at any body locations | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2022-002443-21 | Sponsor Protocol Number: CO44195 | Start Date*: 2023-03-01 | ||||||||||||||||
Sponsor Name:F. HOFFMANN - LA ROCHE LTD. | ||||||||||||||||||
Full Title: A PHASE II, SINGLE-ARM STUDY OF GIREDESTRANT IN PATIENTS WITH GRADE 1 ENDOMETRIAL CANCER | ||||||||||||||||||
Medical condition: Grade 1 Endometrial Cancer | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002491-10 | Sponsor Protocol Number: Alofisel-4001 | Start Date*: 2020-03-10 | |||||||||||
Sponsor Name:Takeda Development Center Americas, Inc. | |||||||||||||
Full Title: Postauthorization Safety Study of the Long-Term Safety and Efficacy of Repeat Administration of Darvadstrocel in Patients With Crohn’s Disease and Complex Perianal Fistula | |||||||||||||
Medical condition: Perianal fistulising Crohn´s disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Trial now transitioned) ES (Ongoing) DE (Trial now transitioned) FR (Ongoing) AT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.